PeptideDB

GADGVGKSA

CAS: 2032119-68-7 F: C30H52N10O13 W: 760.79

GADGVGKSA is a mutant KRAS G12D 9mer peptide. GADGVGKSA can be used as an immunogenic neoantigen for cancer immunotherap
Sales Email：peptidedb@qq.com
Contact QiTai

This product is for research use only, not for human use. We do not sell to patients.

Bioactivity GADGVGKSA is a mutant KRAS G12D 9mer peptide. GADGVGKSA can be used as an immunogenic neoantigen for cancer immunotherapy research[1].
Name GADGVGKSA
CAS 2032119-68-7
Sequence Gly-Ala-Asp-Gly-Val-Gly-Lys-Ser-Ala
Shortening GADGVGKSA
Formula C30H52N10O13
Molar Mass 760.79
Transport Room temperature in continental US; may vary elsewhere.
Storage

Please store the product under the recommended conditions in the Certificate of Analysis.
Reference [1]. Bai P, et al. Characters of neoantigens in cancer immunotherapy. bioRxiv, 2019: 700732.

Furan-2-carboxamide-d3

(±)-1-Amino-2-phenylpropane-1,1,3,3,3-d5 (hydrochloride)

Product Recommendation

Latest release

Hot list

Copyright © 2025 PeptideDB All Rights Reserved

Sitemaps | Contact

Is for research use only, not for human use. We do not sell to patients.